OR4F29 activators belong to a specialized class of chemical compounds that have garnered attention in the field of molecular biology and sensory perception. These compounds are designed to modulate the activity of OR4F29, a protein-coding gene that is a member of the olfactory receptor (OR) gene family. OR4F29, also known as Olfactory Receptor Family 4 Subfamily F Member 29, is primarily expressed in olfactory sensory neurons found in the nasal epithelium and plays a pivotal role in the detection and discrimination of specific odorant molecules. OR4F29 activators function by targeting specific regulatory elements within the OR4F29 gene, typically situated in promoter or enhancer regions, with the primary objective of enhancing its transcription and subsequent translation into functional olfactory receptors.
The mechanisms through which OR4F29 activators exert their effects may vary, but their core purpose is to act as molecular switches, amplifying the activity of OR4F29. Researchers are continually exploring the potential applications and implications of OR4F29 activation, aiming to deepen our understanding of how this gene contributes to the sense of smell and olfactory perception. This class of compounds holds promise for advancing our knowledge of sensory perception, particularly within the context of olfactory receptors, offering insights into the intricate mechanisms that govern our ability to detect and distinguish various odorant molecules and the significance of OR4F29 in shaping our olfactory experiences. OR4F29 activators serve as valuable tools in the ongoing exploration of molecular biology, providing opportunities to uncover the complex roles that OR4F29 plays in sensory functions and its potential involvement in the intricate world of olfaction.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Spiperone | 749-02-0 | sc-471047 | 250 mg | $130.00 | ||
As a dopamine antagonist, spiperone might indirectly affect signaling pathways that regulate gene expression such as OR4F29. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin can modulate epigenetic marks and affect gene expression, which may include OR4F29. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol has been shown to activate sirtuins, potentially affecting the regulation of gene expression, including OR4F29. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium influences GSK-3β signaling, which may impact the transcriptional regulation of genes like OR4F29. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and metabolism, potentially affecting OR4F29 expression. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $46.00 $92.00 $117.00 | 3 | |
As a plant hormone, salicylic acid also affects mammalian cells and might influence gene expression. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Arsenic trioxide can affect transcription factors and signaling pathways, potentially modifying OR4F29 expression. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $63.00 $173.00 | 7 | |
Cobalt chloride can mimic hypoxia and activate hypoxia-inducible factors (HIFs), potentially affecting gene expression. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
As a glucocorticoid, dexamethasone can regulate gene expression via glucocorticoid response elements. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Isoproterenol is a β-adrenergic agonist that could impact cAMP pathways and potentially influence OR4F29 expression. | ||||||